This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carey, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carey, W. B.
Related Collections
Right arrow Office Practice

PEDIATRICS Vol. 105 No. 4 April 2000, pp. 863-864

COMMENTARY:
What the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder Did and Did Not Say About the Use of Methylphenidate for Attention Deficits

The first 20% of the full text of this article appears below.

The December 1999 issue of the Archives of General Psychiatry contained 2 articles1,2 and a commentary3 about the Multimodal Treatment Study of Children with attention-deficit/hyperactivity disorder (ADHD; MTA). At the time of publication the findings were reported widely in the general press with varying degrees of accuracy. A common misperception has been created that it concluded that methylphenidate (Ritalin) is the sole answer for children's problems with inattentiveness and activity and that behavioral management is not particularly beneficial. This commentary reviews what the report actually did and did not say. Misunderstandings by practitioners, teachers, and insurance companies could have unfortunate consequences.

WHAT DID THE REPORT SAY?

  1. In describing this 14-month investigation of 579 elementary school children 7 to 9 years of age, the National Institute of Mental Health press release announced: "The MTA study has demonstrated, on average, that carefully monitored medication management with monthly follow-up, with input from teachers, is more effective than intensive behavioral treatment for ADHD. The combination of medication management and intensive behavioral treatments was also significantly superior to psychosocial treatments . . . [Full Text of this Article]


This article has been cited by other articles:


Home page
 CMAJHome page
H. M. Schachter, B. Pham, J. King, S. Langford, and D. Moher
How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis
Can. Med. Assoc. J., November 1, 2001; 165(11): 1475 - 1488.
[Abstract] [Full Text] [PDF]